WESAIL's Debut at CACLP
- Time of issue:2021-03-30 16:55
WESAIL's Debut at CACLP
(Dongguan, China, March 29, 2021) The 18th China Association of Clinical Laboratory Practice Expo was held in Chongqing from March 28 to March 30, 2021. WESAIL was proud to be part of this year’s grand exhibition with the debut of self-research and developed Immunofluorescence POCT Solution, especially the brand new COVID-19 rapid test reagent kits.
Over thousands of manufacturing enterprises, distributing enterprises, professionals, medical workers, venture investment companies and academic scholars from the IVD industry attended CACLP exhibition due to its iconic profession and influence in the industry. After one year of fighting the global pandemic, WESAIL has grown into a mature, advanced biotechnology company by overcoming different kinds of challenges. Fortunately, WESAIL also achieved different kinds of accomplishments to repay the effort made by all the staffs, scholars, customers whoever showed their support to WESAIL.
WESAIL COVID-19 Diagnotic Test Family is able to detect coronavirus in the incubation period, infection period and post vaccine period to help the medical workers to diagnose and screening within 6-15 minutes, no analyzers needed. Which had become the most frequently consulted product during the exhibition because of its advanced performance and the ability to help the medical workers to faster diagnoses and restrain the epidemic.
During the CACLP exhibition, WESAIL showed a series of the self-research and developed Immunofluorescence POCT analyzers and reagents, the analyzers have advantages of rapid, accurate, convenient, compact and display-friendly, also with the test menu of cardiac, fertility, inflammation, thyroid, lung, renal injury, stomach, metabolism, diabetes, and anemia.
As a socially accountable company, WESAIL has never stopped helping international society to fight the global epidemic. Since 2020, WESAIL has developed and produced series of COVID-19 antigen test reagents, including COVID-19 Antigen, COVID-19 Neutralizing Antibody, Flu+COVID-19 Antigen, COVID-19 IgM/IgG. The COVID-19 series has been approved by medical regulatory authorities and sold to German, Italy, Russia, Romania, Basil, Span, South Korea, Japan and others. Meanwhile, WESAIL is developing the COVID-19 Ag Self-Test Kit, to make the diagnoses much easier and faster.
WESAIL will continuously dedicate itself to the IVD industry and the faith to “Strive for Excellence, Truth and Reality”. WESAIL look forward to helping mankind to defeat COVID-19 and start a new era.